Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mar Barrantes Cepas

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Neuroimaging Clinics of North America|June 28, 2024
Network Analysis in Multiple Sclerosis and Related DisordersGiuseppe Pontillo, Mar Barrantes Cepas, Tommy A A Broeders, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2025
Treatment effects of cladribine tablets on data-driven patterns of regional grey matter atrophy in multiple sclerosisMar Barrantes-Cepas, Samantha Noteboom, Elisa Colato, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Enhancing the interpretability of spinal cord atrophy in multiple sclerosis by reducing interindividual variability due to anatomical differencesDaan J de Jong, Tom A Fuchs, Mar Barrantes-Cepas, et al.
Neuroimage. Clinical|October 8, 2024
Scanner-specific optimisation of automated lesion segmentation in MSDavid R van Nederpelt, Giuseppe Pontillo, Mar Barrantes-Cepas, et al.
JAMA Neurology|December 9, 2024
Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical TrialEline M E Coerver, Wing Hee Fung, Janet de Beukelaar, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Neuroimaging Clinics of North America|June 28, 2024
Network Analysis in Multiple Sclerosis and Related DisordersGiuseppe Pontillo, Mar Barrantes Cepas, Tommy A A Broeders, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 26, 2025
Treatment effects of cladribine tablets on data-driven patterns of regional grey matter atrophy in multiple sclerosisMar Barrantes-Cepas, Samantha Noteboom, Elisa Colato, et al.
Multiple Sclerosis and Related Disorders|February 20, 2026
Enhancing the interpretability of spinal cord atrophy in multiple sclerosis by reducing interindividual variability due to anatomical differencesDaan J de Jong, Tom A Fuchs, Mar Barrantes-Cepas, et al.
Neuroimage. Clinical|October 8, 2024
Scanner-specific optimisation of automated lesion segmentation in MSDavid R van Nederpelt, Giuseppe Pontillo, Mar Barrantes-Cepas, et al.
JAMA Neurology|December 9, 2024
Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis: The DOT-MS Randomized Clinical TrialEline M E Coerver, Wing Hee Fung, Janet de Beukelaar, et al.
Pageof 1